The structural basis for the specificity of epidermal growth factor and heregulin binding. 1995

E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
Pfizer Central Research, Groton, Connecticut 06340, USA.

Heregulin is a ligand for the erbB3 and erbB4 receptors, with a region of high homology to epidermal growth factor (EGF). Despite this homology, these ligands bind to their corresponding receptors with great specificity. We report here the synthesis of heregulin beta 177-241 and show that a region consisting of amino acids 177-226 is sufficient both for binding and stimulation of receptor phosphorylation. Studies of chimeric EGF/heregulin peptides revealed that amino acids 177-181 of heregulin provide the specificity for binding to the heregulin receptor. The substitution of amino acids 177-181 of heregulin for the N terminus of EGF produced a unique bifunctional agonist that binds with high affinity to both the EGF receptor and the heregulin receptor.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
January 1989, Progress in growth factor research,
E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
October 2003, The Journal of biological chemistry,
E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
April 2005, Cancer cell,
E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
June 2001, Urology,
E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
November 1976, Immunochemistry,
E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
June 2008, Journal of virology,
E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
December 1997, Cell,
E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
February 1993, Biochemical and biophysical research communications,
E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
January 1985, Methods in enzymology,
E G Barbacci, and B C Guarino, and J G Stroh, and D H Singleton, and K J Rosnack, and J D Moyer, and G C Andrews
November 1988, The Journal of biological chemistry,
Copied contents to your clipboard!